Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-08-059815
Filing Date
2008-03-18
Accepted
2008-03-18 13:32:30
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 946571
2 SUPPLY AND DISTRIBUTION AGREEMENT dex1061.htm EX-10.61 174548
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 3139
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1589
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 3949
6 CERTIFICATION BY THE CEO dex311.htm EX-31.1 10054
7 CERTIFICATION BY THE CFO dex312.htm EX-31.2 10104
8 CERTIFICATION BY THE CEO PURSUANT TO 18 U.S.C. 1350 dex321.htm EX-32.1 3188
9 CERTIFICATION BY THE CFO PURSUANT TO 18 U.S.C. 1350 dex322.htm EX-32.2 3450
10 GRAPHIC g73121chart.jpg GRAPHIC 43132
  Complete submission text file 0001193125-08-059815.txt   1217641
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23265 | Film No.: 08695711
SIC: 2834 Pharmaceutical Preparations